Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $2.0 million.

  • Cryo Cell International's Other Operating Expenses fell 1436.36% to $2.0 million in Q3 2025 from the same period last year, while for Aug 2025 it was $8.0 million, marking a year-over-year decrease of 6778.73%. This contributed to the annual value of $8.1 million for FY2024, which is 6751.35% down from last year.
  • Latest data reveals that Cryo Cell International reported Other Operating Expenses of $2.0 million as of Q3 2025, which was down 1436.36% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Other Operating Expenses peaked at $18.2 million during Q4 2023, and registered a low of $1.8 million during Q4 2024.
  • For the 5-year period, Cryo Cell International's Other Operating Expenses averaged around $3.2 million, with its median value being $2.3 million (2024).
  • Per our database at Business Quant, Cryo Cell International's Other Operating Expenses soared by 60024.75% in 2023 and then plummeted by 8989.51% in 2024.
  • Cryo Cell International's Other Operating Expenses (Quarter) stood at $3.6 million in 2021, then fell by 27.11% to $2.6 million in 2022, then soared by 600.25% to $18.2 million in 2023, then plummeted by 89.9% to $1.8 million in 2024, then increased by 8.26% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.0 million for Q2 2025, and $2.2 million during Q1 2025.